News RSS Bioethics News.

05/23/2018

F.D.A. Names and Shames Drug Makers to Encourage Generic Competition

External Link - Source: Washington Post

On Thursday, the F.D.A. took a new tack and began posting a list of makers of brand-name drugs that have been the target of complaints, to persuade them to “end the shenanigans,” in the commissioner’s words. Dr. Gottlieb calls it transparency, but this approach is better known among ethicists as naming and shaming.

This entry was posted in Pharmaceuticals and tagged . Bookmark the permalink.